Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, Jennifer D. Lau, Luis G. Gómez-Escobar, Lunkun Ma, Ankit Gilani, Sergio Alvarez-Mulett, Evan Sholle, Vasuretha Chandar, Yaron Bram, Katherine Hoffman, Priya Bhardwaj, Phoebe Piloco, Alfonso Rubio‐Navarro, Skyler Uhl, Lucía Carrau, Sean Houhgton, David Redmond, Alpana P. Shukla, Parag Goyal, Kristy A. Brown, Benjamin R. tenOever, Laura Alonso, Robert E. Schwartz, Edward J. Schenck, Monika M. Safford, James C. Lo
Topics & Concepts
Adipose tissueInsulin resistanceARDSInfectivityAdiponectinMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)InsulinInternal medicineVirologyImmunologyEndocrinologyBiologyBioinformaticsLungVirusInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesVitamin C and Antioxidants Research